Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Bill Palmer | 19:24 uur EDT 5 april 2020 Palmer Rapport " Analyse Donald Trump zei dat hij vandaag geen persconferentie gaf. Toen kwam hij erachter dat Joe Biden om 19.00 uur een live persbriefing deed, dus besloot Trump dat hij een persconferentie moest houden om - je raadt het al - 19.00 uur. We zijn er nog maar een paar minuten mee bezig, en dit is al... hoe moet ik het zelfs maar omschrijven? Trump begon met een gemene aanval op de gouverneur van Illinois. Toen draaide hij snel om hydroxychloroquine te promoten als een veilige en goedgekeurde micacle remedie voor coronavirus, terwijl hydroxychloroquine in feite een drug is met potentieel fatale bijwerkingen die niet goed is getest op coronavirus. Trump probeerde ook het populaire antibioticum azithromycine als coronaviruskuur te promoten, maar uiteindelijk noemde hij het "aritzomyicine" voordat hij zichzelf stopte en het vervolgens weer "aritzomyicine" noemde. We weten niet eens waar we naar kijken. Dit is een giftige afvalstortplaats van waanzin, vol met gevaarlijke valse informatie, en verwant aan een zeer ongelukkige parodie. We raden je aan om Joe Biden's live-evenement te bekijken
please enjoy this video: video 2:09 minuuttwitter.com/AndrewBatesNC/status/1246...
Dr Fauci krijgt een vraag van de pers over Hydroxychloroquine Trump die naast Fauci staat geeft Fauci geen kans de vraag te beantwoorden. video 0:17 minuuttwitter.com/TrueFactsStated/status/12... Trump kan in iedere speech wel vertellen hoe goed het wondermiddel Hydroxychloroquine wel niet is. Wanneer de vraag aan een kenner wordt gesteld, die nog veel voorbehoud voor het middel heeft, dan komt hij de boel verstoren. Wat een mannetje
Hydroxychloroquine U.S. President Donald Trump’s former personal attorney Michael Cohen testified on Wednesday (27 2 2019) that Swiss drugmaker Novartis AG initially wanted him to lobby for the company when it retained him with a $1.2 million contract, but that Cohen refused. “Novartis sent me their contract, which stated specifically that they wanted me to lobby. That they wanted me to provide access to government, including the president, “ Cohen said.www.reuters.com/article/us-usa-trump-... Novartis betaalde $ 1,2 million om dicht bij Trump en zijn administratie in het Witte Huis te komen. Novartis is een grote producent (niet de enige) van Hydroxychloroquine Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic responsewww.novartis.com/news/media-releases/... En wie is de grootste promotor van Hydroxychloroquine ? Donald Trump Wat schuift het Donald, iedere keer dat jij het medicijn aanprijst in speeches die wereldwijd worden uitgezonden? Of heeft de Trump familie een groot pakket aandelen in Novartis ? En is dat de reden dat je Fauci onderbreekt wanneer hij op het podium een vraag over Hydroxychloroquine krijgt. Ook nog een bonus van Novartis voor het doen verstommen van Fauci die vooralsnog zijn bedenkingen heeft over de effectiviteit van het middel tegen het Corona virus. video 0:17 minuuttwitter.com/TrueFactsStated/status/12...
A reporter asks Trump about an AP (Associated Press) finding that the Feds didn’t start adding to its stockpile of ventilators, masks and PPE until mid-March, months after the crisis was indicated. The POTUS cuts him off, slimes the AP and then hides behind FEMA and the military, never answering. Video 0:52 minuuttwitter.com/davidaxelrod/status/12469...
America is behind the curve on the coronavirus because we’re being led by *the* American idiot. video 1:24twitter.com/davidaxelrod/status/12469...
luchtschip schreef op 6 april 2020 03:49 :
Dr Fauci krijgt een vraag van de pers over Hydroxychloroquine
Trump die naast Fauci staat geeft Fauci geen kans de vraag te beantwoorden.
video 0:17 minuut
twitter.com/TrueFactsStated/status/12... Trump kan in iedere speech wel vertellen hoe goed het wondermiddel Hydroxychloroquine wel niet is.
Wanneer de vraag aan een kenner wordt gesteld, die nog veel voorbehoud voor het middel heeft, dan komt hij
de boel verstoren.
Wat een mannetje
Donald weet heel goed wat hij aan het doen is. Het is nu voor hem alles of niets. Als hij nog een jaar moet wachten op het goed gekeurde medicijn dan is hij failliet. De winstgevende zaken van hem zijn gesloten. Hij heeft al aanvragen bij de banken ingestuurd om de aflossingen uit te stellen. Hij is of wordt straat arm. Hij weet ook dat hij misschien niet meer gekozen wordt. Dus hij wordt het haasje. Stel dat het medicijn wat hij nu promoot met puur geluk helpt, dan scoort hij punten. Hij heeft gewoon geen keus in zijn met zijn ego en ziekelijke narcisme. Donald denk alleen maar aan zich zelf en overleven.
Ohio lawmaker RepGalonski says she is making a criminal referral today to the International Criminal Court for Trump to be charged with crimes against humanity over his hydroxychloroquine promotion.twitter.com/funder/status/12471580905... * Michael Cohen sold WH access to #Norvartis for $1.2M * Trump met with CEO Vasant Narasimhan in January at Davos * Giuliani bought 2M Shares in Feb & promoted heavily on Fox News * 28M doses of hydroxychloroquine purchased by U.S. It's all about #TrumpCrimesAgainstHumanitytwitter.com/MusicReviewer7/status/124... Trump en zijn kliek proberen een financieel slaatje te slaan uit de corona crisis door een medicijn te promoten, waarvan dr Fauci zegt te twijfelen of dit het juiste medicijn is om het virus te bestrijden.
Biden leidt in Florida polls 6 pt op trump. Joe Biden is leading President Trump in the swing state of Florida as the president faces skepticism from voters on his response to the coronavirus pandemic. A University of North Florida poll asked registered Florida voters whether they would vote for Trump or the former vice president in November should Biden be the nominee. Biden earned 46% support, while the president had 40%. That is an increase for Biden, the likely Democratic presidential nominee, from UNF's last online poll conducted in February, when he led Trump by 1 point. It is also larger than the RealClearPolitics average of Florida matchup polls, with Biden barely leading Trump by 0.4%.www.washingtonexaminer.com/news/biden...
The Acting Secretary of the Navy Thomas Modly blasted the now ousted commander of the USS Theodore Roosevelt as "stupid" in an address to the ship's crew Monday morning, in remarks obtained by CNN. Modly told the crew that their former commander, Capt. Brett Crozier, was either "too naive or too stupid" to be in command or that he intentionally leaked to the media a memo in which he warned about coronavirus spreading aboard the aircraft carrier and urged action to save his sailors. The acting secretary accused Crozier of committing a "betrayal" and creating a "big controversy" in Washington by disseminating the warning so widely. "It was a betrayal. And I can tell you one other thing: because he did that he put it in the public's forum and it is now a big controversy in Washington, DC," Modly said, according to a transcript of remarks Modly made to the crew, copies of which have been provided to CNN by multiple Navy officials. Het. Is Allemaal. Tuig.www.cnn.com/2020/04/06/politics/uss-t...
Terecht dat ze een Commander ontslaan die Corona ging tanken in Vietnam! En dat nog wel met een nucleair aangedreven vliegdekschip :)) Of is het aan komen waaien??
Al Kipone schreef op 6 april 2020 19:10 :
The Acting Secretary of the Navy Thomas Modly blasted the now ousted commander of the USS Theodore Roosevelt as "stupid" in an address to the ship's crew Monday morning, in remarks obtained by CNN.
Modly told the crew that their former commander, Capt. Brett Crozier, was either "too naive or too stupid" to be in command or that he intentionally leaked to the media a memo in which he warned about coronavirus spreading aboard the aircraft carrier and urged action to save his sailors.
The acting secretary accused Crozier of committing a "betrayal" and creating a "big controversy" in Washington by disseminating the warning so widely.
"It was a betrayal. And I can tell you one other thing: because he did that he put it in the public's forum and it is now a big controversy in Washington, DC," Modly said, according to a transcript of remarks Modly made to the crew, copies of which have been provided to CNN by multiple Navy officials.
Het. Is Allemaal. Tuig.
www.cnn.com/2020/04/06/politics/uss-t... luister:soundcloud.com/paul-szoldra/acting-se...
Poll: 40% of 2016 Trump voters say the president didn’t take the coronavirus threat seriously enough, a 17-point increase from week 1 of tracking. 66% of Independents, and 66% of Americans overall, say the same. Trump Failed to Take Action at a Critical Stage Six in ten Americans say Trump’s failure to act early raises serious concerns, with people of color especially concerned about Trump’s early inaction. Even among white Americans with no 4-year degree, half (48%) worry the president did not act in time. Most independents (61%) also say they are seriously concerned about Trump’s early inaction. Most Call President Trump “Unprepared” A clear majority of Americans say that “unprepared” applies to Trump’s coronavirus response. The majority of white non-college Americans (53%) say that “unprepared” applies to Trump’s coronavirus response and people of color are even more likely to agree. While 61% say Trump is unprepared, 52% say he is “chaotic” and “erratic,” and 51% say he is “irresponsible.” En dat gaat zo nog even door....navigatorresearch.org/public-opinion-...
George W. Bush in 2005 predicted the need for America to prepare for a pandemic. President Obama then dedicated a team to prepare for a pandemic. Donald Trump closed down Obama’s pandemic team in 2018. And... now here we are.twitter.com/JamesKosur/status/1246811... abcnews.go.com/Politics/george-bush-2...
Some good news: the number of daily new #coronavirus cases *appears* to be starting to flatten.???? It will take a bit longer for the number of daily new #COVID19 deaths to flatten, but it WILL happen soon. PLEASE #StayHomepbs.twimg.com/media/EU36pR6WAAIhc3w?f... tweede tweet :twitter.com/DrDenaGrayson/status/1246... The number of daily #COVID19 deaths in the US now exceeds *all* other countries (#China not accurate). Sadly, daily #coronavirus deaths will continue to rise, until ~2 weeks AFTER we #FlattenTheCurve of new cases. The next 3-5 weeks will be brutal.pbs.twimg.com/media/EU3ys9BXYAUDyn3?f... twitter.com/DrDenaGrayson/status/1246...
Queen addresses the nation: 'We will meet again' The Queen has delivered a historic, stirring address to the nation during the coronavirus lockdown. video 4:13 minuuttwitter.com/TimOBrien/status/12469020... She doesn’t mention her ratings.
Pharma-Funded Group Tied to a Top Trump Donor Is Promoting Malaria Drug to the President Founded by one of Trump's top donors, the Job Creators Network has been pushing Trump to approve the use of hydroxychloroquine for treating COVID-19.twitter.com/CREWcrew/status/124720768... A fight broke out among the White House coronavirus task force over the weekend regarding the potential use of anti-malarial drug hydroxychloroquine for COVID-19 patients. According to a report from Axios, National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci objected to task force members’ characterizations of the drug, saying that there was only anecdotal evidence of the drug’s effectiveness and cautioning that much more data is needed. Fauci’s comments set off a heated exchange with Trump economic advisor Peter Navarro, who reportedly raised his voice and accused Fauci of being the only task force member who had objected to Trump’s China travel ban. It was the first such confrontation among the task force, according to Axios’ source. Since late March, President Trump has repeatedly promoted the use of the drug, despite the limited testing that has been done on its effectiveness for treating COVID-19. On Sunday, Trump reiterated his support for using it to treat coronavirus patients. “What do you have to lose?,” Trump asked, repeating his comments from Saturday. Trump also prevented Dr. Fauci from fielding a question on the use of hydroxychloroquine. It’s unclear why Trump has been such a proponent of hydroxychloroquine, but one answer may lie with the millions of dollars in political support he has received from the founder of a pharmaceutical industry-funded group that has been pushing him to make the drug available. On March 26, Job Creators Network, a conservative dark money nonprofit, launched a petition, a series of Facebook ads, and a blast text message campaign calling on Trump to “cut the red tape” and immediately make hydroxychloroquine available to treat patients. “There is clear and ever-mounting evidence that the anti-malaria drug hydroxychloroquine can significantly help patients who contract coronavirus,” the petition states, despite the lack of rigorous clinical testing. readsludge.com/2020/04/06/pharma-fund...
Former Vice President Joe Biden and President Trump have spoken by phone about the response to the coronavirus pandemic, sources saytwitter.com/CNN/status/12472730609206... edition.cnn.com/2020/04/06/politics/b...
The next big failure: "Trump Pharmacies."twitter.com/TeaPainUSA/status/1247248... ‘A really chilling moment’: Trump refuses to allow Dr. Fauci to answer question on dangers of hydroxychloroquine “This is unacceptable. Dr. Fauci, one of the world’s top infectious disease scientists, was just censored live at a White House press conference.” During a press briefing Sunday night purportedly aimed at providing the U.S. public with crucial information amid the ongoing coronavirus pandemic, President Donald Trump refused to allow the nation’s top infectious disease expert to answer a reporter’s question about the efficacy of an anti-malaria drug that the president has recklessly touted as a possible COVID-19 treatment despite warnings from medical professionals. Before Dr. Anthony Fauci could respond to the question about hydroxychloroquine, Trump—who was standing back and off to the side of the podium—complained that Fauci had already spoken about the drug “15 times.” “You don’t have to ask the question again,” said Trump, stepping forward and moving closer to Fauci as another reporter began asking a separate question. “This is a really chilling moment from a science standpoint, with Trump having just pushed an unproven COVID treatment and Fauci, the top infectious disease expert in the U.S., getting muzzled on live TV,” tweeted Andrew Freedman, a climate reporter for the Washington Post. “Was clear Trump didn’t want to be contradicted.” Dr. Lucky Tran, a biologist, said Trump’s interruption was “unacceptable.” “Dr. Fauci, one of the world’s top infectious disease scientists, was just censored live at a White House press conference,” tweeted Tran. The exchange came just hours after Fauci, in an appearance on CBS‘ “Face the Nation” Sunday morning, said that “in terms of science, I don’t think we could definitively say [hydroxychloroquine] works.” “The data are really just at best suggestive,” said Fauci. “There have been cases that show there may be an effect and there are others to show there’s no effect.” During a press briefing Saturday evening, Trump said “I really think they should they should take it,” referring to coronavirus patients and hydroxychloroquine. Three people in Nigeria overdosed on the drug last month after the president said, without evidence, that the drug may be able to combat the novel coronavirus. In a joint statement on March 25, the American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists said “there is no incontrovertible evidence to support off-label use of medications for COVID-19.” “What do I know?” Trump asked during the press briefing Sunday night. “I’m not a doctor.”www.rawstory.com/2020/04/a-really-chi...
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
881,78
+0,30%
EUR/USD
1,0788
-0,22%
FTSE 100
7.952,62
+0,26%
Germany40^
18.505,40
+0,15%
Gold spot
2.234,24
+1,92%
NY-Nasdaq Composite
16.399,52
+0,51%
Stijgers
Dalers